{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:45:54Z","timestamp":1762875954003},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background and objectives<\/jats:title>\n            <jats:p>The response to immunosuppressive therapy in autoimmune hepatitis (AIH) is a matter of debate. The aim of this work is to identify the histological, biochemical, and clinical predictive factors of incomplete response\/treatment failure to the standard treatment (prednisone with or without azathioprine) in a well-characterized series of AIH Egyptian patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and methods<\/jats:title>\n            <jats:p>Of 49 AIH patients, only 36 patients completed this retrospective cohort study. The immunological, biochemical, histopathological, and clinical characteristics of patients were evaluated at diagnosis and during follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients were classified into two groups; group A showed a complete response to therapy (<jats:italic toggle=\"yes\">n<\/jats:italic>=22; 61%) and group B showed partial response\/treatment failure (<jats:italic toggle=\"yes\">n<\/jats:italic>=14; 39%). In a multivariate analysis, we observed that age at diagnosis up to 22 years [odds ratio (OR): 23.22; confidence interval (CI): 3.978\u2013135.549; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001], serum albumin up to 3.2\u2009g\/dl (OR: 5.36; CI: 1.237\u201323.209; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.025), mean platelet volume (MPV) of at least 10.75\u2009fl (OR: 16.5; CI: 3.093\u201388.037; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and presence of cirrhosis at diagnosis (OR: 8.44; CI: 1.682\u201342.392; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001) were independent variables that can predict partial response\/treatment failure. MPV correlated positively with stages of fibrosis\/cirrhosis and grades of activity in liver biopsy at diagnosis and correlated inversely with serum albumin and age at presentation. During therapy, group B showed a fluctuation in MPV levels, however, group A showed a progressive decline until the end point.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study confirmed that younger age, hypoalbuminemia, increased MPV, and cirrhosis at diagnosis were all independent predictors of incomplete response\/treatment failure in AIH patients. MPV may reflect the response to therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000000982","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T18:05:57Z","timestamp":1507917957000},"page":"1373-1379","source":"Crossref","is-referenced-by-count":10,"title":["New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume"],"prefix":"10.1097","volume":"29","author":[{"given":"Ahmed","family":"Abdel-Razik","sequence":"first","affiliation":[{"name":"Tropical Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Mousa","sequence":"additional","affiliation":[{"name":"Tropical Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Tropical Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Elhelaly","sequence":"additional","affiliation":[{"name":"Clinical Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Elzehery","sequence":"additional","affiliation":[{"name":"Clinical Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Zalata","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Awad","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Mansoura University, Mansoura, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Eldeeb","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Abdelsalam","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis\u2013 current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women","volume":"16","author":"Lee","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","author":"Mieli-Vergani","year":"2009","journal-title":"Semin Liver Dis"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"American Association For the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term out-come in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"J239","DOI":"10.1016\/j.jaut.2011.12.002","article-title":"Outcomes of pregnancy in women with autoimmune hepatitis","volume":"38","author":"Westbrook","year":"2012","journal-title":"J Autoimmun"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","article-title":"Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery","volume":"97","author":"Buchel","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean platelet volume: a link between thrombosis and inflammation?","volume":"17","author":"Gasparyan","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R21-20230916","first-page":"361","article-title":"From precursor to product: how do megakaryocytes produce platelets?","volume":"215","author":"Thompson","year":"1986","journal-title":"Prog Clin Biol Res"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V72.1.1.1","article-title":"The pathophysiology and clinical relevance of platelet heterogeneity","volume":"72","author":"Thompson","year":"1988","journal-title":"Blood"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinre.2012.03.035","article-title":"Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis","volume":"37","author":"Purnak","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00508-013-0394-3","article-title":"A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis Binfection","volume":"125","author":"Ceylan","year":"2013","journal-title":"Wien Klin Wochenschr"},{"key":"R25-20230916","first-page":"1580","article-title":"The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease","volume":"59","author":"Kurt","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/MEG.0000000000000202","article-title":"Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection","volume":"26","author":"Abdel-Razik","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R27-20230916","first-page":"40","article-title":"Thrombocytopenia as a sensitive marker of immunologic activity in a patient with autoimmune chronic active hepatitis","volume":"28","author":"Persico","year":"1996","journal-title":"Ital J Gastroenterol"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1824-7288-36-42","article-title":"Immune disease expressed in liver and platelets in an adolescent: a case report","volume":"36","author":"Antunes","year":"2010","journal-title":"Ital J Pediatr"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ajh.2830500305","article-title":"Platelet autoantibodies in patients with chronic liver disease","volume":"50","author":"Pereira","year":"1995","journal-title":"Am J Hematol"},{"key":"R30-20230916","first-page":"121","article-title":"Hepatoportal sclerosis associated with portal vein thrombosis in children: report of 3 cases","volume":"34","author":"Hessel","year":"1997","journal-title":"Arq Gastroenterol"},{"key":"R31-20230916","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s10620-006-9596-0","article-title":"Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis","volume":"52","author":"Koksal","year":"2007","journal-title":"Di Dis Sci"},{"key":"R32-20230916","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcla.20450","article-title":"Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B","volume":"25","author":"Ekiz","year":"2011","journal-title":"J Clin Lab Anal"},{"key":"R33-20230916","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.dld.2016.06.018","article-title":"Predictive factors of poor response to therapy in autoimmune hepatitis","volume":"48","author":"Muratori","year":"2016","journal-title":"Dig Liver Dis"},{"key":"R34-20230916","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/hep.26290","article-title":"Predictors of poor outcome in patients with autoimmune hepatitis: a population-based study","volume":"57","author":"Ngu","year":"2013","journal-title":"Hepatology"},{"key":"R35-20230916","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptomsand cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"R36-20230916","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.25658","article-title":"Long-term outcome of Japanese patients with type 1 autoimmune hepatitis","volume":"56","author":"Yoshizawa","year":"2012","journal-title":"Hepatology"},{"key":"R37-20230916","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042737-201712000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T15:03:36Z","timestamp":1694876616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201712000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000000982","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}